101 related articles for article (PubMed ID: 16631476)
1. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
[TBL] [Abstract][Full Text] [Related]
2. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
3. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
[TBL] [Abstract][Full Text] [Related]
4. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV.
Ng TL; O'Sullivan MJ; Pallen CJ; Hayes M; Clarkson PW; Winstanley M; Sorensen PH; Nielsen TO; Horsman DE
J Mol Diagn; 2007 Sep; 9(4):459-63. PubMed ID: 17620387
[TBL] [Abstract][Full Text] [Related]
5. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
[TBL] [Abstract][Full Text] [Related]
6. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
7. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
8. EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.
Wakahara K; Ohno T; Kimura M; Masuda T; Nozawa S; Dohjima T; Yamamoto T; Nagano A; Kawai G; Matsuhashi A; Saitoh M; Takigami I; Okano Y; Shimizu K
Mol Cancer Res; 2008 Dec; 6(12):1937-45. PubMed ID: 19074838
[TBL] [Abstract][Full Text] [Related]
9. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
10. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
12. The EWS protein is dispensable for Ewing tumor growth.
Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
[TBL] [Abstract][Full Text] [Related]
13. A new member of the ETS family fused to EWS in Ewing tumors.
Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
[TBL] [Abstract][Full Text] [Related]
14. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
[TBL] [Abstract][Full Text] [Related]
15. The Biology of Ewing sarcoma.
Riggi N; Stamenkovic I
Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
Wang H; Zheng J; Wang YP; Yang Y; You JF
Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
[TBL] [Abstract][Full Text] [Related]
17. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
[TBL] [Abstract][Full Text] [Related]
18. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M
Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855
[TBL] [Abstract][Full Text] [Related]
19. EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
[TBL] [Abstract][Full Text] [Related]
20. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
